SACT Pathways, Guidelines for the Management of SACT Induced Adverse Reactions and Nursing 

SACT Pathways 

• For emergency 24 hour telephone advice refer to local Trust policy  
• Bisphoshonate Guidelines incorporating prescribing in Renal Impairment v2 
• Extravasation v5 (Funding arrangements for Savene are outstanding but are currently being addressed through Acute Trusts D&Ts)  
• Guidelines for the Management of SACT Induced Nausea and Vomiting v6
  
• Guidelines for Use of G-CSF in Adult Haematology and Oncology Patients v6
  
• Handling, Administration, Health and Safety v3
  
• Hypercalcaemia Guidelines v4
  
• Intrathecal: refer to local Trust policy

   

• Guidelines on the Safe Use of Oral Anti-Cancer Medicines v6
  
• Neutropenic sepsis  (Please refer to individual Trust policies for the Antimicrobial Management of Neutropenia) 
  
• Preparation and Pharmacy 
  
• SACT Anaphylaxis v4
  
• SACT Guidelines for the Management of Systemic Anti-Cancer Therapy Induced Diarrhoea Pathway of Care v6
  
• SACT Induced Mucositis & Stomatitis 
  
• Location of Delivery of Systemic Anti-Cancer Therapy (SACT): refer to local Trust policy         
  
• UK Chemotherapy Board Guidance on DPD testing
  
• Vascular Access Guidelines 

Guidelines for the Management of SACT Induced Adverse Reactions

• Guidelines for Bevacizumab induced hypertension v1 (Reviewed Nov 13)  
• Guidelines for Cetuximab induced rashes v3 
  
• Ipilimumab-related toxicity Management of Diarrhoea v1
• Ipilimumab-related toxicity Management of Endocrinopathy v1
• Ipilimumab-related toxicity Management of Hepatotoxicity v1
• Ipilimumab-related toxicity Management of Neurological Reactions v1
• Ipilimumab-related toxicity Management of Skin Toxicities v1
• Guidance on the assessment and Management of Oxaliplatin induced Neuropathy v1
• Dose modification schedule & management of adverse reactions to Vemurafenib v1 
  

• Management of Immunotherapy-Related Adverse Events:
  The KMCC Chemotherapy Group have reviewed the St Luke’s Cancer Alliance Guidelines for Management of Immunotherapy-Related Adverse Events and with the kind permission of St Luke’s Cancer Alliance, have agreed to adopt these for use within KMCC.
  
  https://www.royalsurrey.nhs.uk/download.cfm?doc=docm93jijm4n7176.pdf&ver=20133

Nursing 

Palliative Care Guidelines

• Palliative Care Guideline Plus Website

Training and Workforce

• KMCC nurses training documents under review to be updated shortly